Literature DB >> 23242655

Mutant p53 binds to estrogen receptor negative promoter via DNMT1 and HDAC1 in MDA-MB-468 breast cancer cells.

Rita Arabsolghar1, Tayebeh Azimi, Mozhgan Rasti.   

Abstract

DNA methylation and histone deacetylation are two epigenetic mechanisms involved in the lack of estrogen receptor (ER) expression. Our previous studies demonstrated that mutant p53 along with repression complex proteins including DNMT1, HDAC1 and MeCP2 is associated with ER-negative promoter in MDA-MB-468 cells. To elucidate the molecular mechanism of estrogen receptor 1 (ESR1) gene silencing in these cells, we down-regulated DNMT1 and HDAC1 expression using siRNAs and studied the ability of DNMT1, HDAC1, MeCP2 and p53 in binding to ESR1 promoter CpG island. Our results showed that DNMT1 or HDAC1 down-regulation disassembled the repression complex proteins and mutant p53 from ER-negative promoter. The partial demethylation of ESR1 promoter and ER re-expression in down-regulated cells supports these findings. In vivo binding studies demonstrated that mutation of p53 protein in this cell line did not affect its binding capacity to DNMT1, HDAC1 and MeCP2 proteins. Our observations suggest that not only histone deacetylase activity of HDAC1 contributes to inactivation of methylated ESR1 gene but also HDAC1 presence on ESR1 promoter is important for assembly of DNMT1 in repression complex. In addition, our data revealed that mutant p53 protein binds to the promoter of ESR1 through direct interaction with HDAC1 and indirect interaction with DNMT1, MeCP2 proteins in the ER-negative MDA-MB-468 cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23242655     DOI: 10.1007/s11033-012-2348-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  43 in total

Review 1.  Emerging connections between DNA methylation and histone acetylation.

Authors:  J R Dobosy; E U Selker
Journal:  Cell Mol Life Sci       Date:  2001-05       Impact factor: 9.261

2.  Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1.

Authors:  Hiromichi Kimura; Kunio Shiota
Journal:  J Biol Chem       Date:  2002-12-06       Impact factor: 5.157

3.  Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition.

Authors:  X Yang; A T Ferguson; S J Nass; D L Phillips; K A Butash; S M Wang; J G Herman; N E Davidson
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

Review 4.  Regulation of DNA methyltransferase 1 by interactions and modifications.

Authors:  Weihua Qin; Heinrich Leonhardt; Garwin Pichler
Journal:  Nucleus       Date:  2011-09-01       Impact factor: 4.197

5.  DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.

Authors:  M Okano; D W Bell; D A Haber; E Li
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

Review 6.  Epigenomics and breast cancer.

Authors:  Pang-Kuo Lo; Saraswati Sukumar
Journal:  Pharmacogenomics       Date:  2008-12       Impact factor: 2.533

7.  p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest.

Authors:  Jenny S L Ho; Weili Ma; Daniel Y L Mao; Samuel Benchimol
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

8.  Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression.

Authors:  Mohammad Obaidul Hoque; Maria Prencipe; Maria Luana Poeta; Raffaela Barbano; Vanna Maria Valori; Massimiliano Copetti; Antonietta Pia Gallo; Mariana Brait; Evaristo Maiello; Adolfo Apicella; Raffaele Rossiello; Francesco Zito; Tommasi Stefania; Angelo Paradiso; Massimo Carella; Bruno Dallapiccola; Roberto Murgo; Illuminato Carosi; Michele Bisceglia; Vito Michele Fazio; David Sidransky; Paola Parrella
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-09-29       Impact factor: 4.254

9.  Promoter methylation of O(6)-methylguanine-DNA-methyltransferase in lung cancer is regulated by p53.

Authors:  Ji-Ching Lai; Ya-Wen Cheng; Yih-Gang Goan; Jinghua Tsai Chang; Tzu-Chin Wu; Chih-Yi Chen; Huei Lee
Journal:  DNA Repair (Amst)       Date:  2008-06-13

Review 10.  One function--multiple mechanisms: the manifold activities of p53 as a transcriptional repressor.

Authors:  Levin Böhlig; Karen Rother
Journal:  J Biomed Biotechnol       Date:  2011-03-08
View more
  4 in total

1.  TP53 Binding to BRCA1 and RAD51 in MCF7 and MDA-MB-468 Breast Cancer Cell Lines In vivo and In vitro.

Authors:  Mozhgan Rasti; Tayebeh Azimi
Journal:  Avicenna J Med Biotechnol       Date:  2015 Apr-Jun

Review 2.  Specific or not specific recruitment of DNMTs for DNA methylation, an epigenetic dilemma.

Authors:  Eric Hervouet; Paul Peixoto; Régis Delage-Mourroux; Michaël Boyer-Guittaut; Pierre-François Cartron
Journal:  Clin Epigenetics       Date:  2018-02-09       Impact factor: 6.551

3.  Associating expression and genomic data using co-occurrence measures.

Authors:  Maarten Larmuseau; Lieven P C Verbeke; Kathleen Marchal
Journal:  Biol Direct       Date:  2019-05-09       Impact factor: 4.540

Review 4.  Comprehensive analysis of regulation of DNA methyltransferase isoforms in human breast tumors.

Authors:  Mangala Hegde; Manjunath B Joshi
Journal:  J Cancer Res Clin Oncol       Date:  2021-02-18       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.